- Email: [email protected]
JAMDA Maintains Excellent Impact Factor
JAMDA 18 (2017) 737e740
JAMDA journal homepage: www.jamda.com
Editorial
JAMDA Maintains Excellent Impact Factor John E. Morley MB, BCh * Division of Geriatric Medicine, Saint Louis University School of Medicine, St. Louis, Missouri
Over the past decade, JAMDA has had strong growth in its impact factor (Figure 1). In 2016, it was ranked fourth among all journals in geriatrics and gerontology with an impact factor of 5.775 (Table 1). It also had a 5-year impact factor of 5.449 and an immediacy index of 1.381. Of the top 30 articles1e30 in the period covered for the 2016 impact factor, 9 were on sarcopenia (Table 2). Other highly cited articles were those on advance care planning (3), nursing home research priorities (5), the INTERACT quality improvement program (6), the Brain Health consensus (7), and an article on transitions in frailty states (9). The top
Table 2 All-Time Top 30 Cited JAMDA Articles as of June 21, 2017 Rank
First Author
Year
Subject
No. of Citations
1 2 3 4 5 6
Chen LK1 Bauer JM2 Houben CHM3 Woo J4 Morley JE5 Ouslander JG6
2014 2015 2014 2014 2014 2014
267 64 59 56 51 50
7
Morley JE7
2015
8
Sarcopenia in Asia consensus Vitamin D, leucine-enriched whey Advance care planning review Validating the SARC-F International survey-NH Research Reduce acute care transfersINTERACT Brain health: IAGG consensus conference Frailty, sarcopenia, and diabetes Transitions in frailty states Defining sarcopenia, adverse outcomes Frailty screening using FRAIL scale SMART study, resistance/cognitive training Quality of life, quality of care, dementia Motoneuron loss associated with sarcopenia No nonresponders to resistance exercise Prevalence of sarcopenia geriatric patients Delirium superimposed on dementia Reasons for hospitalization, dementia Cognitive and physical stimulation therapy Regional white matter lesions predict falls Obesity and physical frailty, a review Mild cognitive impairment, treatable Aging and multimorbidity: New tasks Mediterranean diet and risk of frailty Nurse staffing impact on quality of care Rapid Geriatric Assessment Instruments to assess sarcopenia, frailty Addressing malnutrition, feedME study Inappropriate drug prescribing and polypharmacy Sarcopenia, incident disability, mortality
28
8 9 10
Morley JE Lee JS9 Woo J10
2014 2014 2015
11 12
Woo J11 FiataroneSingh MA12 Beerens HC13
2015 2014
7 6 5 4 3
13
2 1 0
2008
2009
2010
2011
2012
2013
2014
2015
2016
Fig. 1. JAMDA’s impact factor 2008e2016.
Rank Journal 1 2 3 4 5 6 7 8 9 10
Impact Factor 5-Year Immediacy Impact Factor Index
Ageing Res Rev 7.452 Aging Cell 6.714 J Gerontol A Biol Sci Med Sci 5.957 J Am Med Dir Assoc 5.775 Neurobiol Aging 5.117 Aging Dis 4.648 Front Aging Neurosci 4.504 J Am Geriatr Soc 4.388 Age Ageing 4.282 Gerontology 4.252
8.084 6.456 5.783 5.449 4.949 4.100 4.602 5.185 4.553 3.824
2.069 1.700 1.213 1.381 0.851 1.106 0.367 0.556 0.714 0.776
Drey M
15
ChurchwardVenne TA15 Smoliner C16
2014 2014 2014
Morandi A Afram B18
19
Loraine J19
2014
20
Ogama N20
2014
21 22
21
Starr KN Morley JE22
2014 2014
23
Fabbri E23
2015
24
Leon-Munoz LM24 Backhaus R25
2014
25 26 27
29
http://dx.doi.org/10.1016/j.jamda.2017.06.033 1525-8610/Ó 2017 AMDA e The Society for Post-Acute and Long-Term Care Medicine.
17
2015
17 18
28
* Address correspondence to John E. Morley, MB, BCh, Division of Geriatric Medicine, Saint Louis University School of Medicine, 1402 S, Grand Boulevard, M238, St Louis, MO 63104. E-mail address: [email protected].
2014 2014
14
16
Table 1 Impact Factor, 5-Year Impact Factor, and Immediacy Index for the Top 10 Journals in Geriatrics and Gerontology
14
30
26
2014
Morley JE Mijnarends DM27 Correia M28
2015 2015
29
2014
Morley JE Hirani V
30
2014
2015
49 49 48 44 42 42 39 38 36 35 34 34 31 31 29 29 28 28
26 26 26 25 23
738
Editorial / JAMDA 18 (2017) 737e740
Table 3 JAMDA Articles That Have Been Cited 100 Times or More Rank
First Author
Year
Subject
No. of Citations
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Fielding RA36 Morley JE37 Morley JE38 Bauer J39 Chen LK1 Morley JE40 Michaud M41 van Kan GA42 Gobbens RJ43 Tieland M44 Sinclair A45 Bostick JE46 Tieland M47 Rolland Y48 Rockwood K49 Landi F50 Tolson D51 Thakur M52 Singh NA53 Banks MR54 Gobbens RJJ55 Bales CW56
2011 2013 2011 2013 2014 2010 2013 2008 2010 2012 2012 2006 2012 2008 2007 2012 2011 2008 2012 2008 2010 2008
Sarcopenia: An undiagnosed condition Frailty consensus: A call to action Sarcopenia with limited mobility Optimal dietary protein intake position paper Sarcopenia in Asia: Consensus report Nutritional recommendations, management of sarcopenia Proinflammatory cytokines, aging diseases Frailty: Toward a clinical definition The Tilburg Frailty Indicator: Psychometric Protein supplements increase muscle mass, exercise Diabetes mellitus position statement IAGG Review, staffing and quality in nursing homes Protein supplement improves physical performance, frailty Physical activity and Alzheimer disease How to grade frailty in nursing home patients Sarcopenia and mortality, nursing home IAGG agenda, clinical research, nursing home Depression in long-term care High-intensity progressive training, treat frailty Animal-assisted therapy and loneliness Determinants of frailty Is obesity bad for older persons? Review
635 474 279 272 267 197 175 175 160 159 156 150 140 137 136 127 125 112 105 105 102 100
5 cited in 2016 were the articles on exercise effects on frailty,31 frailty as an emerging public health policy,32 physical exercise and dementia,33 the recognition of sarcopenia with an International Classification of Diseases, 10th Revision, Clinical Modification code,34 and the role of frailty and sarcopenia as predictors of outcomes in older persons with diabetes.35 Table 3 lists the 22 articles in JAMDA that have been cited 100 or more times.36e56 The articles cited more than 50 times in the 4 major clinical geriatric journals, viz, Journals of Gerontology: Series A Medical and
Biological Sciences, JAMDA, Journal of the American Geriatrics Society, and Age and Ageing are given in Table 4.1e6,57e79 As can be seen in Figure 2, JAMDA has shown steady growth in the number of submissions. Despite this, the median time from submission to first decision remains an impressive 14 days. JAMDA remains a truly international journal, with articles published in 2016 coming from 32 countries (Figure 3). The editor thanks his associate editors, the editorial board, and the reviewers for helping to make the journal so successful. A special
Table 4 Most Cited Articles in JAMDA, Journals of Gerontology: Series A, Journal of the American Geriatrics Society, and Age and Ageing Rank
First Author
Year
Journal
Subject
Total No. Citations
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Chen LK1 Franceschi C57 Radcliff S58 Cruz-Jentoft AJ59 Studenski SA60 O’Mahony D61 Rebok GW62 Dam TT63 McLean RR64 Cesari M65 Moore DR66 Zhang Y67 Alley DE68 Kales HC69 Sardar P70 Malmstrom TK71 Pathai S72 Atkins JL73 Bauer JM2 Houben CHM3 Volpato S74 Woo J4 Tucsek Z75 Cawthon PM76 Fried TR77 Cesari M78 Theou O79 Morley JE5 Ouslander JG6
2014 2014 2015 2014 2014 2015 2014 2014 2014 2014 2015 2014 2014 2014 2014 2014 2014 2014 2015 2014 2014 2014 2014 2014 2014 2015 2014 2014 2014
JAMDA J Gerontol A Biol J Am Geriatr Soc Age Ageing J Gerontol A Biol Age Ageing J Am Geriatr Soc J Gerontol A Biol J Gerontol A Biol Age Ageing J Gerontol A Biol J Gerontol A Biol J Gerontol A Biol J Am Geriatr Soc J Am Geriatr Soc J Am Geriatr Soc J Gerontol A Biol J Gerontol A Biol JAMDA JAMDA J Gerontol A Biol JAMDA J Gerontol A Biol J Gerontol Series J Am Geriatr Soc J Gerontol Series J Am Geriatr Soc JAMDA JAMDA
Sarcopenia in Asia Chronic inflammation Updated Beers criteria International sarcopenia initiative FNIH sarcopenia project STOPP/START criteria Advanced cognitive training Operational criteria-sarcopenia Weakness and low lean mass Frailty phenotype and index Protein stimulate myofibrillar Rapamycin extends life: mice Grip strength cutpoints: weak Neuropsychiatric symptoms of dementia New oral anticoagulants Compare 4 frailty models HIV-model accelerated aging Sarcopenic obesity: cardiovascular disease Vitamin D and whey protein: sarcopenia Efficacy-Advance Care Plan Sarcopenia-community elders Validate SARC-Fecommunity Obesity in aging: Alzheimer disease Cutpoints-lean mass-weakness Outcomes-polypharmacy Activity to treat frailty Characteristics-frailty-7 scales International survey: nursing home research Reduce transfers QI program
269 243 191 182 177 165 131 92 90 79 75 75 74 69 68 67 66 65 64 60 59 56 56 56 52 48 52 51 50
Sci Med Sci
Sci Med Sci
Sci Med Sci Sci Med Sci Sci Med Sci Sci Med Sci Sci Med Sci
Sci Med Sci Sci Med Sci
Sci Med Sci Sci Med Sci A A
Editorial / JAMDA 18 (2017) 737e740
800 600 400 200
0
2008
2009
2010
2011
2012
2013
2014
2015
2016
Fig. 2. Growth in submissions.
100 90 80 70 60 50 40 30 20 10 0
Fig. 3. Number of published articles from various countries in 2016. *Rest of the world includes fewer than 6 articles published in 2016 from each of the following countries: Austria, Brazil, Finland, Ireland, Israel, Luxembourg, Malaysia, Mexico, New Zealand, Norway, Poland, Portugal, Slovakia, Slovenia, South Korea, Switzerland, Turkey, and the United Kingdom.
Fig. 4. Managing Editor Valerie Tanner and Editor-in-Chief John E. Morley receiving an award from Chris Laxton, Executive Director of AMDA e The Society for Post-Acute and Long-Term Care Medicine at the 2017 Annual Conference in Phoenix.
thanks goes to our stoic managing editor, Valerie Tanner, who was honored at the annual meeting of AMDA: The Society for Post-Acute and Long-Term Care Medicine (Figure 4). References 1. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95e101. 2. Bauer JM, Verlaan S, Bautmans I, et al. Effects of a vitamin D and leucineenriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: A randomized, double-blind, controlled trial. J Am Med Dir Assoc 2015;16:740e747.
739
3. Houben CHM, Spruit MA, Groenen MTJ, et al. Efficacy of advance care planning: A systematic review and meta-analysis. J Am Med Dir Assoc 2014;15:477e489. 4. Woo J, Leung J, Morley JE. Validating the SARC-F: A suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014;15:630e634. 5. Morley JE, Caplan G, Cesari M, et al. International survey of Nursing Home Research priorities. J Am Med Dir Assoc 2014;15:309e312. 6. Ouslander JG, Bonner A, Herndon L, et al. The Interventions to Reduce Acute Care Transfers-INTERACT quality improvement program: An overview for medical directors and primary care clinicians in long term care. J Am Med Dir Assoc 2014;15:162e170. 7. Morley JE, Morris JC, Berg-Weger M, et al. Brain health: The importance of recognizing cognitive impairment: An IAGG consensus conference. J Am Med Dir Assoc 2015;16:731e739. 8. Morley JE, Malmstrom TK, Rodriguez-Manas L, et al. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc 2014;15:853e859. 9. Lee JSW, Auyeung TW, Leung J, et al. Transitions in frailty states among community-living older adults and their associated factors. J Am Med Dir Assoc 2014;15:281e286. 10. Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc 2015;16:247e252. 11. Woo J, Yu R, Wong M, et al. Frailty screening in the community using the FRAIL scale. J Am Med Dir Assoc 2015;16:412e419. 12. Fiatarone Singh MA, Gates N, Saigal N, et al. The study of mental and resistance training (SMART) studyeresistance training and/or cognitive training in mild cognitive impairment: A randomized, double-blind, double-sham controlled trial. J Am Med Dir Assoc 2014;15:873e880. 13. Beerens HC, Sutcliffe C, Renom-Guiteras A, et al. Quality of life and quality of care for people with dementia receiving long term institutional care or professional home care: The European RightTimePlace Care Study. J Am Med Dir Assoc 2014;15:54e61. 14. Drey M, Krieger B, Sieber CC, et al. DISARCO study group. Motoneuron loss is associated with sarcopenia. J Am Med Dir Assoc 2014;15:435e439. 15. Churchward-Venne TA, Tieland M, Verdijk LB, et al. There are no nonresponders to resistance-type exercise training in older men and women. J Am Med Dir Assoc 2015;16:400e411. 16. Smoliner C, Sieber CC, Wirth R. Prevalence of sarcopenia in geriatric hospitalized patients. J Am Med Dir Assoc 2014;15:267e272. 17. Morandi A, Davis D, Fick DM, et al. Delirium superimposed on dementia strongly predicts worse outcomes in older rehabilitation inpatients. J Am Med Dir Assoc 2014;15:349e354. 18. Afram B, Stephen A, Verbeek H, et al. Reasons for institutionalization of people with dementia: Informal caregiver reports from 8 European countries. J Am Med Dir Assoc 2014;15:108e116. 19. Loraine J, Taylor S, McAllister M. Cognitive and physical stimulation therapy. J Am Med Dir Assoc 2014;15:140e141. 20. Ogama N, Sakurai T, Shimizu A, et al. Regional white matter lesions predict falls in patients with amnestic mild cognitive impairment and Alzheimer’s disease. J Am Med Dir Assoc 2014;15:36e41. 21. Starr KNP, McDonald SR, Bales CW. Obesity and physical frailty in older adults: A scoping review of lifestyle intervention trials. J Am Med Dir Assoc 2014;15: 240e250. 22. Morley JE. Mild cognitive impairmentda treatable condition. J Am Med Dir Assoc 2014;15:1e5. 23. Fabbri E, Zoli M, Gonzalez-Freire M, et al. Aging and multimorbidity: New tasks, priorities, and frontiers for integrated gerontological and clinical research. J Am Med Dir Assoc 2015;16:640e647. 24. Leon-Munoz LM, Guallar-Castillon P, Lopez-Garcia E, et al. Mediterranean diet and risk of frailty in community-dwelling older adults. J Am Med Dir Assoc 2014;15:899e903. 25. Backhaus R, Verbeek H, van Rossum E, et al. Nurse staffing impact on quality of care in nursing homes: A systematic review of longitudinal studies. J Am Med Dir Assoc 2014;15:383e393. 26. Morley JE, Adams EV. Rapid geriatric assessment. J Am Med Dir Assoc 2015;16: 808e812. 27. Mijnarends DM, Schols JMGA, Meijers JMM, et al. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: Similarities and discrepancies. J Am Med Dir Assoc 2015;16:301e308. 28. Correia MITD, Hegazi RA, Higashiguchi T, et al. Evidence-based recommendations for addressing malnutrition in health care: An updated strategy from the feedME global study group. J Am Med Dir Assoc 2014;15:544e550. 29. Morley JE. Inappropriate drug prescribing and polypharmacy are major causes of poor outcomes in long-term care. J Am Med Dir Assoc 2014;15:780e782. 30. Hirani V, Blyth F, Naganathan V, et al. Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: The Concord Health and Ageing in Men project. J Am Med Dir Assoc 2015;16:607e613. 31. Tarazona-Santabalbina JF, Gomez-Cabrera MC, Perez-Ros P, et al. A multicomponent exercise intervention that reverses frailty and improves cognition, emotion, and social networking in the community-dwelling frail elderly: A randomized clinical trial. J Am Med Dir Assoc 2016;17:426e433. 32. Cesari M, Prince M, Tiyagarjan JA, et al. Frailty: An emerging public health priority. J Am Med Dir Assoc 2016;17:188e192. 33. Brett L, Traynor V, Stapley P. Effects of physical exercise on health and wellbeing of individuals living with a dementia in nursing homes: A systematic review. J Am Med Dir Assoc 2016;17:104e116.
740
Editorial / JAMDA 18 (2017) 737e740
34. Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an International Classification of Diseases, Tenth revision, Clinical Modification (ICD-10-CM) code. J Am Med Dir Assoc 2016;17:675e677. 35. Liccini AP, Malmstrom TK. Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. J Am Med Dir Assoc 2016; 17:846e851. 36. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011;12:249e256. 37. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: A call to action. J Am Med Dir Assoc 2013;14:392e397. 38. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 2011;12:403e409. 39. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE study group. J Am Med Dir Assoc 2013;14:542e559. 40. Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010;11:391e396. 41. Michaud M, Balardy L, Moulis G, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 2013;14:877e882. 42. Van Kan GA, Rolland YM, Morley JE, et al. Frailty: Toward a clinical definition. J Am Med Dir Assoc 2008;9:71e72. 43. Gobbens RJJ, van Assen MALM, Luijkx KG, et al. The Tilburg frailty indicator: Psychometric properties. J Am Med Dir Assoc 2010;11:344e355. 44. Tieland M, Dirks ML, van der Zwaluw N, et al. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: A randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012;13:713e719. 45. Sinclair A, Morley JE, Rodriguez-Manas L, et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012;13:497e502. 46. Bostick JE, Rantz MJ, Flexner MK, et al. Systematic review of studies of staffing and quality in nursing homes. J Am Med Dir Assoc 2006;7:366e376. 47. Tieland M, van de Rest O, Dirks ML, et al. Protein supplementation improves physical performance in frail elderly people: A randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012;13:720e726. 48. Rolland Y, van Kan GA, Velals B. Physical activity and Alzheimer’s disease: From prevention to therapeutic perspectives. J Am Med Dir Assoc 2008;9:390e405. 49. Rockwood K, Abeysundera MJ, Mitnitski A. How should we grade frailty in nursing home patients? J Am Med Dir Assoc 2007;8:595e603. 50. Landi F, Liperoti R, Fusco D, et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 2012;13:121e126. 51. Tolson D, Rolland Y, Andrieu S, et al. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc 2011;12:184e189. 52. Thakur M, Blazer DG. Depression in long-term care. J Am Med Dir Assoc 2008; 9:82e87. 53. Singh NA, Quine S, Clemson LM, et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. J Am Med Dir Assoc 2012;13:24e30. 54. Banks MR, Willoughby LM, Banks WA. Animal-assisted therapy and loneliness in nursing homes: Use of robotic versus living dogs. J Am Med Dir Assoc 2008; 9:173e177. 55. Gobbens RJJ, van Assen MALM, Luijkx KG, et al. Determinants of frailty. J Am Med Dir Assoc 2010;11:356e364. 56. Bales CW, Buhr G. Is obesity bad for older persons? A systematic review of the pros and cons of weight reduction in later life. J Am Med Dir Assoc 2008;9:302e312. 57. Franceschi C, Campisi J. Chronic inflammation (Inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 2014; 69(Suppl 1):S4eS9. 58. Radcliff S, Yue J, Rocco G, et al. American Geriatrics Society 2015 Updated Beers criteria for potential inappropriate medication use in older adults. J Am Geriatr Soc 2015;63:2227e2246.
59. Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Intitiative (EWGSOP and IWGS). Age Ageing 2014;43:748e759. 60. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014;69:547e558. 61. O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing 2015;44: 213e218. 62. Rebok GW, Ball K, Guey LT, et al. Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults. J Am Geriatr Soc 2014;62:16e24. 63. Dam TT, Peters KW, Fragala M, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci 2014;69:584e590. 64. McLean RR, Shardell MD, Alley DE, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: The Foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci 2014;69: 576e583. 65. Cesari M, Gambassi G, van Kan GA, et al. The frailty phenotype and the frailty index: Different instruments for different purposes. Age Ageing 2014;43: 10e12. 66. Moore DR, Churchward-Venne TA, Witard O, et al. Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men. J Gerontol A Biol Sci Med Sci 2015;70: 57e62. 67. Zhang Y, Bokov A, Gelfond J, et al. Rapamycin extends life and health in C57BL/ 6 mice. J Gerontol A Biol Sci Med Sci 2014;69:119e130. 68. Alley DE, Shardell MD, Peters KW. Grip strength cutpoints for the identification of clinically relevant weakenss. J Gerontol A Biol Sci Med Sci 2014;69: 559e566. 69. Kales HC, Gitlin LN, Lyketsos CG. Management of neuropsychiatric symptoms of dementia in clinical settings: Recommendations from a multidisciplinary expert panel. J Am Geriatr Soc 2014;62:762e769. 70. Sardar P, Chatterjee S, Chaudhari S, et al. New oral anticoagulants in elderly adults: Evidence from a meta-analysis of randomized trials. J Am Geriatr Soc 2014;62:857e864. 71. Malmstrom TK, Miller DK, Morley JE. A comparison of four frailty models. J Am Geriatr Soc 2014;62:721e726. 72. Pathai S, Bajillan H, Landay AL, et al. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2014;69:833e842. 73. Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: A population-based cohort study of older men. J Am Geriatr Soc 2014;62:253e260. 74. Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: Application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 2014;69: 438e446. 75. Tucsek Z, Toth P, Sosnowska D, et al. Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: Effects on expression of gene involved in beta-amyloid generation and Alzheimer’s disease. J Gerontol A Biol Sci Med Sci 2014;69: 1212e1226. 76. Cawthon PM, Peters KW, Shardell MD, et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci 2014;69:567e575. 77. Fried TR, O’Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: A systematic review. J Am Geriatr Soc 2014;62:2261e2272. 78. Cesari M, Vellas B, Hsu FC, et al. A physical activity intervention to treat the frailty syndrome in older personsdresults from the LIFE-P study. J Gerontol A Biol Sci Med Sci 2015;70:216e222. 79. Theou O, Brothers TD, Pena FG, et al. Identifying common characteristics of frailty cross seven scales. J Am Geriatr Soc 2014;62:901e906.
JAMDA journal homepage: www.jamda.com
Editorial
JAMDA Maintains Excellent Impact Factor John E. Morley MB, BCh * Division of Geriatric Medicine, Saint Louis University School of Medicine, St. Louis, Missouri
Over the past decade, JAMDA has had strong growth in its impact factor (Figure 1). In 2016, it was ranked fourth among all journals in geriatrics and gerontology with an impact factor of 5.775 (Table 1). It also had a 5-year impact factor of 5.449 and an immediacy index of 1.381. Of the top 30 articles1e30 in the period covered for the 2016 impact factor, 9 were on sarcopenia (Table 2). Other highly cited articles were those on advance care planning (3), nursing home research priorities (5), the INTERACT quality improvement program (6), the Brain Health consensus (7), and an article on transitions in frailty states (9). The top
Table 2 All-Time Top 30 Cited JAMDA Articles as of June 21, 2017 Rank
First Author
Year
Subject
No. of Citations
1 2 3 4 5 6
Chen LK1 Bauer JM2 Houben CHM3 Woo J4 Morley JE5 Ouslander JG6
2014 2015 2014 2014 2014 2014
267 64 59 56 51 50
7
Morley JE7
2015
8
Sarcopenia in Asia consensus Vitamin D, leucine-enriched whey Advance care planning review Validating the SARC-F International survey-NH Research Reduce acute care transfersINTERACT Brain health: IAGG consensus conference Frailty, sarcopenia, and diabetes Transitions in frailty states Defining sarcopenia, adverse outcomes Frailty screening using FRAIL scale SMART study, resistance/cognitive training Quality of life, quality of care, dementia Motoneuron loss associated with sarcopenia No nonresponders to resistance exercise Prevalence of sarcopenia geriatric patients Delirium superimposed on dementia Reasons for hospitalization, dementia Cognitive and physical stimulation therapy Regional white matter lesions predict falls Obesity and physical frailty, a review Mild cognitive impairment, treatable Aging and multimorbidity: New tasks Mediterranean diet and risk of frailty Nurse staffing impact on quality of care Rapid Geriatric Assessment Instruments to assess sarcopenia, frailty Addressing malnutrition, feedME study Inappropriate drug prescribing and polypharmacy Sarcopenia, incident disability, mortality
28
8 9 10
Morley JE Lee JS9 Woo J10
2014 2014 2015
11 12
Woo J11 FiataroneSingh MA12 Beerens HC13
2015 2014
7 6 5 4 3
13
2 1 0
2008
2009
2010
2011
2012
2013
2014
2015
2016
Fig. 1. JAMDA’s impact factor 2008e2016.
Rank Journal 1 2 3 4 5 6 7 8 9 10
Impact Factor 5-Year Immediacy Impact Factor Index
Ageing Res Rev 7.452 Aging Cell 6.714 J Gerontol A Biol Sci Med Sci 5.957 J Am Med Dir Assoc 5.775 Neurobiol Aging 5.117 Aging Dis 4.648 Front Aging Neurosci 4.504 J Am Geriatr Soc 4.388 Age Ageing 4.282 Gerontology 4.252
8.084 6.456 5.783 5.449 4.949 4.100 4.602 5.185 4.553 3.824
2.069 1.700 1.213 1.381 0.851 1.106 0.367 0.556 0.714 0.776
Drey M
15
ChurchwardVenne TA15 Smoliner C16
2014 2014 2014
Morandi A Afram B18
19
Loraine J19
2014
20
Ogama N20
2014
21 22
21
Starr KN Morley JE22
2014 2014
23
Fabbri E23
2015
24
Leon-Munoz LM24 Backhaus R25
2014
25 26 27
29
http://dx.doi.org/10.1016/j.jamda.2017.06.033 1525-8610/Ó 2017 AMDA e The Society for Post-Acute and Long-Term Care Medicine.
17
2015
17 18
28
* Address correspondence to John E. Morley, MB, BCh, Division of Geriatric Medicine, Saint Louis University School of Medicine, 1402 S, Grand Boulevard, M238, St Louis, MO 63104. E-mail address: [email protected].
2014 2014
14
16
Table 1 Impact Factor, 5-Year Impact Factor, and Immediacy Index for the Top 10 Journals in Geriatrics and Gerontology
14
30
26
2014
Morley JE Mijnarends DM27 Correia M28
2015 2015
29
2014
Morley JE Hirani V
30
2014
2015
49 49 48 44 42 42 39 38 36 35 34 34 31 31 29 29 28 28
26 26 26 25 23
738
Editorial / JAMDA 18 (2017) 737e740
Table 3 JAMDA Articles That Have Been Cited 100 Times or More Rank
First Author
Year
Subject
No. of Citations
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Fielding RA36 Morley JE37 Morley JE38 Bauer J39 Chen LK1 Morley JE40 Michaud M41 van Kan GA42 Gobbens RJ43 Tieland M44 Sinclair A45 Bostick JE46 Tieland M47 Rolland Y48 Rockwood K49 Landi F50 Tolson D51 Thakur M52 Singh NA53 Banks MR54 Gobbens RJJ55 Bales CW56
2011 2013 2011 2013 2014 2010 2013 2008 2010 2012 2012 2006 2012 2008 2007 2012 2011 2008 2012 2008 2010 2008
Sarcopenia: An undiagnosed condition Frailty consensus: A call to action Sarcopenia with limited mobility Optimal dietary protein intake position paper Sarcopenia in Asia: Consensus report Nutritional recommendations, management of sarcopenia Proinflammatory cytokines, aging diseases Frailty: Toward a clinical definition The Tilburg Frailty Indicator: Psychometric Protein supplements increase muscle mass, exercise Diabetes mellitus position statement IAGG Review, staffing and quality in nursing homes Protein supplement improves physical performance, frailty Physical activity and Alzheimer disease How to grade frailty in nursing home patients Sarcopenia and mortality, nursing home IAGG agenda, clinical research, nursing home Depression in long-term care High-intensity progressive training, treat frailty Animal-assisted therapy and loneliness Determinants of frailty Is obesity bad for older persons? Review
635 474 279 272 267 197 175 175 160 159 156 150 140 137 136 127 125 112 105 105 102 100
5 cited in 2016 were the articles on exercise effects on frailty,31 frailty as an emerging public health policy,32 physical exercise and dementia,33 the recognition of sarcopenia with an International Classification of Diseases, 10th Revision, Clinical Modification code,34 and the role of frailty and sarcopenia as predictors of outcomes in older persons with diabetes.35 Table 3 lists the 22 articles in JAMDA that have been cited 100 or more times.36e56 The articles cited more than 50 times in the 4 major clinical geriatric journals, viz, Journals of Gerontology: Series A Medical and
Biological Sciences, JAMDA, Journal of the American Geriatrics Society, and Age and Ageing are given in Table 4.1e6,57e79 As can be seen in Figure 2, JAMDA has shown steady growth in the number of submissions. Despite this, the median time from submission to first decision remains an impressive 14 days. JAMDA remains a truly international journal, with articles published in 2016 coming from 32 countries (Figure 3). The editor thanks his associate editors, the editorial board, and the reviewers for helping to make the journal so successful. A special
Table 4 Most Cited Articles in JAMDA, Journals of Gerontology: Series A, Journal of the American Geriatrics Society, and Age and Ageing Rank
First Author
Year
Journal
Subject
Total No. Citations
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Chen LK1 Franceschi C57 Radcliff S58 Cruz-Jentoft AJ59 Studenski SA60 O’Mahony D61 Rebok GW62 Dam TT63 McLean RR64 Cesari M65 Moore DR66 Zhang Y67 Alley DE68 Kales HC69 Sardar P70 Malmstrom TK71 Pathai S72 Atkins JL73 Bauer JM2 Houben CHM3 Volpato S74 Woo J4 Tucsek Z75 Cawthon PM76 Fried TR77 Cesari M78 Theou O79 Morley JE5 Ouslander JG6
2014 2014 2015 2014 2014 2015 2014 2014 2014 2014 2015 2014 2014 2014 2014 2014 2014 2014 2015 2014 2014 2014 2014 2014 2014 2015 2014 2014 2014
JAMDA J Gerontol A Biol J Am Geriatr Soc Age Ageing J Gerontol A Biol Age Ageing J Am Geriatr Soc J Gerontol A Biol J Gerontol A Biol Age Ageing J Gerontol A Biol J Gerontol A Biol J Gerontol A Biol J Am Geriatr Soc J Am Geriatr Soc J Am Geriatr Soc J Gerontol A Biol J Gerontol A Biol JAMDA JAMDA J Gerontol A Biol JAMDA J Gerontol A Biol J Gerontol Series J Am Geriatr Soc J Gerontol Series J Am Geriatr Soc JAMDA JAMDA
Sarcopenia in Asia Chronic inflammation Updated Beers criteria International sarcopenia initiative FNIH sarcopenia project STOPP/START criteria Advanced cognitive training Operational criteria-sarcopenia Weakness and low lean mass Frailty phenotype and index Protein stimulate myofibrillar Rapamycin extends life: mice Grip strength cutpoints: weak Neuropsychiatric symptoms of dementia New oral anticoagulants Compare 4 frailty models HIV-model accelerated aging Sarcopenic obesity: cardiovascular disease Vitamin D and whey protein: sarcopenia Efficacy-Advance Care Plan Sarcopenia-community elders Validate SARC-Fecommunity Obesity in aging: Alzheimer disease Cutpoints-lean mass-weakness Outcomes-polypharmacy Activity to treat frailty Characteristics-frailty-7 scales International survey: nursing home research Reduce transfers QI program
269 243 191 182 177 165 131 92 90 79 75 75 74 69 68 67 66 65 64 60 59 56 56 56 52 48 52 51 50
Sci Med Sci
Sci Med Sci
Sci Med Sci Sci Med Sci Sci Med Sci Sci Med Sci Sci Med Sci
Sci Med Sci Sci Med Sci
Sci Med Sci Sci Med Sci A A
Editorial / JAMDA 18 (2017) 737e740
800 600 400 200
0
2008
2009
2010
2011
2012
2013
2014
2015
2016
Fig. 2. Growth in submissions.
100 90 80 70 60 50 40 30 20 10 0
Fig. 3. Number of published articles from various countries in 2016. *Rest of the world includes fewer than 6 articles published in 2016 from each of the following countries: Austria, Brazil, Finland, Ireland, Israel, Luxembourg, Malaysia, Mexico, New Zealand, Norway, Poland, Portugal, Slovakia, Slovenia, South Korea, Switzerland, Turkey, and the United Kingdom.
Fig. 4. Managing Editor Valerie Tanner and Editor-in-Chief John E. Morley receiving an award from Chris Laxton, Executive Director of AMDA e The Society for Post-Acute and Long-Term Care Medicine at the 2017 Annual Conference in Phoenix.
thanks goes to our stoic managing editor, Valerie Tanner, who was honored at the annual meeting of AMDA: The Society for Post-Acute and Long-Term Care Medicine (Figure 4). References 1. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95e101. 2. Bauer JM, Verlaan S, Bautmans I, et al. Effects of a vitamin D and leucineenriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: A randomized, double-blind, controlled trial. J Am Med Dir Assoc 2015;16:740e747.
739
3. Houben CHM, Spruit MA, Groenen MTJ, et al. Efficacy of advance care planning: A systematic review and meta-analysis. J Am Med Dir Assoc 2014;15:477e489. 4. Woo J, Leung J, Morley JE. Validating the SARC-F: A suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014;15:630e634. 5. Morley JE, Caplan G, Cesari M, et al. International survey of Nursing Home Research priorities. J Am Med Dir Assoc 2014;15:309e312. 6. Ouslander JG, Bonner A, Herndon L, et al. The Interventions to Reduce Acute Care Transfers-INTERACT quality improvement program: An overview for medical directors and primary care clinicians in long term care. J Am Med Dir Assoc 2014;15:162e170. 7. Morley JE, Morris JC, Berg-Weger M, et al. Brain health: The importance of recognizing cognitive impairment: An IAGG consensus conference. J Am Med Dir Assoc 2015;16:731e739. 8. Morley JE, Malmstrom TK, Rodriguez-Manas L, et al. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc 2014;15:853e859. 9. Lee JSW, Auyeung TW, Leung J, et al. Transitions in frailty states among community-living older adults and their associated factors. J Am Med Dir Assoc 2014;15:281e286. 10. Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc 2015;16:247e252. 11. Woo J, Yu R, Wong M, et al. Frailty screening in the community using the FRAIL scale. J Am Med Dir Assoc 2015;16:412e419. 12. Fiatarone Singh MA, Gates N, Saigal N, et al. The study of mental and resistance training (SMART) studyeresistance training and/or cognitive training in mild cognitive impairment: A randomized, double-blind, double-sham controlled trial. J Am Med Dir Assoc 2014;15:873e880. 13. Beerens HC, Sutcliffe C, Renom-Guiteras A, et al. Quality of life and quality of care for people with dementia receiving long term institutional care or professional home care: The European RightTimePlace Care Study. J Am Med Dir Assoc 2014;15:54e61. 14. Drey M, Krieger B, Sieber CC, et al. DISARCO study group. Motoneuron loss is associated with sarcopenia. J Am Med Dir Assoc 2014;15:435e439. 15. Churchward-Venne TA, Tieland M, Verdijk LB, et al. There are no nonresponders to resistance-type exercise training in older men and women. J Am Med Dir Assoc 2015;16:400e411. 16. Smoliner C, Sieber CC, Wirth R. Prevalence of sarcopenia in geriatric hospitalized patients. J Am Med Dir Assoc 2014;15:267e272. 17. Morandi A, Davis D, Fick DM, et al. Delirium superimposed on dementia strongly predicts worse outcomes in older rehabilitation inpatients. J Am Med Dir Assoc 2014;15:349e354. 18. Afram B, Stephen A, Verbeek H, et al. Reasons for institutionalization of people with dementia: Informal caregiver reports from 8 European countries. J Am Med Dir Assoc 2014;15:108e116. 19. Loraine J, Taylor S, McAllister M. Cognitive and physical stimulation therapy. J Am Med Dir Assoc 2014;15:140e141. 20. Ogama N, Sakurai T, Shimizu A, et al. Regional white matter lesions predict falls in patients with amnestic mild cognitive impairment and Alzheimer’s disease. J Am Med Dir Assoc 2014;15:36e41. 21. Starr KNP, McDonald SR, Bales CW. Obesity and physical frailty in older adults: A scoping review of lifestyle intervention trials. J Am Med Dir Assoc 2014;15: 240e250. 22. Morley JE. Mild cognitive impairmentda treatable condition. J Am Med Dir Assoc 2014;15:1e5. 23. Fabbri E, Zoli M, Gonzalez-Freire M, et al. Aging and multimorbidity: New tasks, priorities, and frontiers for integrated gerontological and clinical research. J Am Med Dir Assoc 2015;16:640e647. 24. Leon-Munoz LM, Guallar-Castillon P, Lopez-Garcia E, et al. Mediterranean diet and risk of frailty in community-dwelling older adults. J Am Med Dir Assoc 2014;15:899e903. 25. Backhaus R, Verbeek H, van Rossum E, et al. Nurse staffing impact on quality of care in nursing homes: A systematic review of longitudinal studies. J Am Med Dir Assoc 2014;15:383e393. 26. Morley JE, Adams EV. Rapid geriatric assessment. J Am Med Dir Assoc 2015;16: 808e812. 27. Mijnarends DM, Schols JMGA, Meijers JMM, et al. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: Similarities and discrepancies. J Am Med Dir Assoc 2015;16:301e308. 28. Correia MITD, Hegazi RA, Higashiguchi T, et al. Evidence-based recommendations for addressing malnutrition in health care: An updated strategy from the feedME global study group. J Am Med Dir Assoc 2014;15:544e550. 29. Morley JE. Inappropriate drug prescribing and polypharmacy are major causes of poor outcomes in long-term care. J Am Med Dir Assoc 2014;15:780e782. 30. Hirani V, Blyth F, Naganathan V, et al. Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: The Concord Health and Ageing in Men project. J Am Med Dir Assoc 2015;16:607e613. 31. Tarazona-Santabalbina JF, Gomez-Cabrera MC, Perez-Ros P, et al. A multicomponent exercise intervention that reverses frailty and improves cognition, emotion, and social networking in the community-dwelling frail elderly: A randomized clinical trial. J Am Med Dir Assoc 2016;17:426e433. 32. Cesari M, Prince M, Tiyagarjan JA, et al. Frailty: An emerging public health priority. J Am Med Dir Assoc 2016;17:188e192. 33. Brett L, Traynor V, Stapley P. Effects of physical exercise on health and wellbeing of individuals living with a dementia in nursing homes: A systematic review. J Am Med Dir Assoc 2016;17:104e116.
740
Editorial / JAMDA 18 (2017) 737e740
34. Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an International Classification of Diseases, Tenth revision, Clinical Modification (ICD-10-CM) code. J Am Med Dir Assoc 2016;17:675e677. 35. Liccini AP, Malmstrom TK. Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. J Am Med Dir Assoc 2016; 17:846e851. 36. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011;12:249e256. 37. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: A call to action. J Am Med Dir Assoc 2013;14:392e397. 38. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 2011;12:403e409. 39. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE study group. J Am Med Dir Assoc 2013;14:542e559. 40. Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010;11:391e396. 41. Michaud M, Balardy L, Moulis G, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 2013;14:877e882. 42. Van Kan GA, Rolland YM, Morley JE, et al. Frailty: Toward a clinical definition. J Am Med Dir Assoc 2008;9:71e72. 43. Gobbens RJJ, van Assen MALM, Luijkx KG, et al. The Tilburg frailty indicator: Psychometric properties. J Am Med Dir Assoc 2010;11:344e355. 44. Tieland M, Dirks ML, van der Zwaluw N, et al. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: A randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012;13:713e719. 45. Sinclair A, Morley JE, Rodriguez-Manas L, et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012;13:497e502. 46. Bostick JE, Rantz MJ, Flexner MK, et al. Systematic review of studies of staffing and quality in nursing homes. J Am Med Dir Assoc 2006;7:366e376. 47. Tieland M, van de Rest O, Dirks ML, et al. Protein supplementation improves physical performance in frail elderly people: A randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012;13:720e726. 48. Rolland Y, van Kan GA, Velals B. Physical activity and Alzheimer’s disease: From prevention to therapeutic perspectives. J Am Med Dir Assoc 2008;9:390e405. 49. Rockwood K, Abeysundera MJ, Mitnitski A. How should we grade frailty in nursing home patients? J Am Med Dir Assoc 2007;8:595e603. 50. Landi F, Liperoti R, Fusco D, et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 2012;13:121e126. 51. Tolson D, Rolland Y, Andrieu S, et al. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc 2011;12:184e189. 52. Thakur M, Blazer DG. Depression in long-term care. J Am Med Dir Assoc 2008; 9:82e87. 53. Singh NA, Quine S, Clemson LM, et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. J Am Med Dir Assoc 2012;13:24e30. 54. Banks MR, Willoughby LM, Banks WA. Animal-assisted therapy and loneliness in nursing homes: Use of robotic versus living dogs. J Am Med Dir Assoc 2008; 9:173e177. 55. Gobbens RJJ, van Assen MALM, Luijkx KG, et al. Determinants of frailty. J Am Med Dir Assoc 2010;11:356e364. 56. Bales CW, Buhr G. Is obesity bad for older persons? A systematic review of the pros and cons of weight reduction in later life. J Am Med Dir Assoc 2008;9:302e312. 57. Franceschi C, Campisi J. Chronic inflammation (Inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 2014; 69(Suppl 1):S4eS9. 58. Radcliff S, Yue J, Rocco G, et al. American Geriatrics Society 2015 Updated Beers criteria for potential inappropriate medication use in older adults. J Am Geriatr Soc 2015;63:2227e2246.
59. Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Intitiative (EWGSOP and IWGS). Age Ageing 2014;43:748e759. 60. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014;69:547e558. 61. O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing 2015;44: 213e218. 62. Rebok GW, Ball K, Guey LT, et al. Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults. J Am Geriatr Soc 2014;62:16e24. 63. Dam TT, Peters KW, Fragala M, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci 2014;69:584e590. 64. McLean RR, Shardell MD, Alley DE, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: The Foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci 2014;69: 576e583. 65. Cesari M, Gambassi G, van Kan GA, et al. The frailty phenotype and the frailty index: Different instruments for different purposes. Age Ageing 2014;43: 10e12. 66. Moore DR, Churchward-Venne TA, Witard O, et al. Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men. J Gerontol A Biol Sci Med Sci 2015;70: 57e62. 67. Zhang Y, Bokov A, Gelfond J, et al. Rapamycin extends life and health in C57BL/ 6 mice. J Gerontol A Biol Sci Med Sci 2014;69:119e130. 68. Alley DE, Shardell MD, Peters KW. Grip strength cutpoints for the identification of clinically relevant weakenss. J Gerontol A Biol Sci Med Sci 2014;69: 559e566. 69. Kales HC, Gitlin LN, Lyketsos CG. Management of neuropsychiatric symptoms of dementia in clinical settings: Recommendations from a multidisciplinary expert panel. J Am Geriatr Soc 2014;62:762e769. 70. Sardar P, Chatterjee S, Chaudhari S, et al. New oral anticoagulants in elderly adults: Evidence from a meta-analysis of randomized trials. J Am Geriatr Soc 2014;62:857e864. 71. Malmstrom TK, Miller DK, Morley JE. A comparison of four frailty models. J Am Geriatr Soc 2014;62:721e726. 72. Pathai S, Bajillan H, Landay AL, et al. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2014;69:833e842. 73. Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: A population-based cohort study of older men. J Am Geriatr Soc 2014;62:253e260. 74. Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: Application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 2014;69: 438e446. 75. Tucsek Z, Toth P, Sosnowska D, et al. Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: Effects on expression of gene involved in beta-amyloid generation and Alzheimer’s disease. J Gerontol A Biol Sci Med Sci 2014;69: 1212e1226. 76. Cawthon PM, Peters KW, Shardell MD, et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci 2014;69:567e575. 77. Fried TR, O’Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: A systematic review. J Am Geriatr Soc 2014;62:2261e2272. 78. Cesari M, Vellas B, Hsu FC, et al. A physical activity intervention to treat the frailty syndrome in older personsdresults from the LIFE-P study. J Gerontol A Biol Sci Med Sci 2015;70:216e222. 79. Theou O, Brothers TD, Pena FG, et al. Identifying common characteristics of frailty cross seven scales. J Am Geriatr Soc 2014;62:901e906.